Pathogenetic Mechanisms of Thrombosis in Malignancy

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Acta Haematologica

• Publication date

  2001-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000046585PMID 11549773
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hemostatic alterations in cancer patients

  2005cited by this paper
• Basic and Clinical Aspects of Fibrinolysis and Thrombolysis

  2003cited by this paper
• The Thrombophilic State in Cancer Patients

  2001cited by this paper
• Platelet/polymorphonuclear leukocyte adhesion: a new role for SRC kinases in Mac-1 adhesive function triggered by P-selectin.

  2001cited by this paper
• Venous Thromboembolism as First Manifestation of Cancer

  2001cited by this paper
• Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera.

  2000cited by this paper
• Warfarin is safe as secondary prophylaxis in patients with cancer and a previous episode of venous thrombosis.

  2000cited by this paper
• Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial.

  2000cited by this paper
• Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor.

  1999cited by this paper
• Venous Thromboembolism as First Manifestation of Cancer

  1999cited by this paper
• Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data.

  1999cited by this paper
• Pathophysiology of the Thrombophilic State in the Cancer Patient

  1999cited by this paper
• P-Selectin-β2-Integrin Cross-Talk: A Molecular Mechanism For Polymorphonuclear Leukocyte Recruitment At The Site Of Vascular Damage

  1999cited by this paper
• Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer.

  1998cited by this paper
• Venous Thromboembolism in Malignancy and Malignancy in Venous Thromboembolism

  1998cited by this paper
• Venous thromboembolism and cancer.

  1998cited by this paper
• Tissue‐factor expression in human non‐small‐cell lung carcinoma measured by immunohistochemistry: Correlation between tissue factor and angiogenesis

  1998cited by this paper
• The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism.

  1998cited by this paper
• The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia.

  1998cited by this paper
• Monocytes.

  1998cited by this paper
• The Effect of Very-low-dose Warfarin on Markers of Hypercoagulation in Metastatic Breast Cancer: Results from a Randomized Trial

  1998cited by this paper
• Clinical Impact of the Plasminogen Activation System in Tumor Invasion and Metastasis: Prognostic Relevance and Target for Therapy

  1997cited by this paper
• Venous thromboembolism and cancer: a two-way clinical association.

  1997cited by this paper
• Monocytes upregulate endothelial cell expression of tissue factor: a role for cell-cell contact and cross-talk.

  1997cited by this paper
• Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue.

  1997cited by this paper
• Tissue Factor in Health and Disease

  1997cited by this paper
• Occult Cancer in Patients with Venous Thromboembolism: which Patients, which Cancers

  1997cited by this paper
• Platelet-leukocyte-endothelial cell interaction on the blood vessel wall.

  1997cited by this paper
• Venous thromboembolism and cancer: a two-way clinical association.

  1997cited by this paper
• Molecular mechanisms linking thrombosis and angiogenesis in cancer.

  1997cited by this paper
• All‐trans‐RETINOIC ACID INCREASES ADHESION TO ENDOTHELIUM OF THE HUMAN PROMYELOCYTIC LEUKAEMIA CELL LINE NB4

  1996cited by this paper
• In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease

  1996cited by this paper
• Tissue factor in cancer angiogenesis and metastasis

  1996cited by this paper
• Thrombosis in Cancer Patients Treated with Hematopoietic Growth Factors - A Meta-Analysis

  1996cited by this paper
• Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid.

  1995cited by this paper
• Cellular Receptors in the Regulation of Plasmin Generation

  1995cited by this paper
• Cancer and Thrombosis: from Phlegmasia Alba Dolens to Transgenic Mice

  1995cited by this paper
• Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer.

  1994cited by this paper
• Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans-retinoic acid.

  1994cited by this paper
• Deep venous thrombosis and occult malignancy: an epidemiological study

  1994cited by this paper
• The hypercoagulable state in cancer patients: evidence for impaired thrombin inhibitions

  1994cited by this paper
• Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice.

  1994cited by this paper
• The importance of blood cell-vessel wall interactions in tumour metastasis.

  1993cited by this paper
• Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery

  1993cited by this paper
• Guidelines for Clotting Studies in Cancer Patients

  1993cited by this paper
• The role of leukocytes in the activation of blood coagulation.

  1992cited by this paper
• Deep-vein thrombosis and the incidence of subsequent symptomatic cancer.

  1992cited by this paper
• Venous thromboembolism and cancer.

  1992cited by this paper
• The role of leukocytes in the activation of blood coagulation.

  1992cited by this paper
• Antiblastic therapy and thrombosis

  1992cited by this paper
• Blood coagulation changes in nude mice bearing human colon carcinomas

  1992cited by this paper
• Basic and clinical aspects of fibrinolysis and thrombolysis.

  1991cited by this paper
• Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer.

  1991cited by this paper
• Cancer Procoagulant in Acute Non Lymphoid Leukemia: Relationship of Enzyme Detection to Disease Activity

  1990cited by this paper
• Chemotherapy enhances endothelial cell reactivity to platelets

  1990cited by this paper
• The induction of a hypercoagulable state by medroxyprogesterone acetate in breast cancer patients

  1990cited by this paper
• Cancer procoagulant in acute lymphoblastic leukemia

  1990cited by this paper
• Animal Tumor Procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society of Thrombosis and Haemostasis

  1990cited by this paper
• Fibrinolysis and Cancer

  1990cited by this paper
• Prevention of Venous Thromboembolism in General, Surgical Patients: Results of a Meta-Analysis

  1989cited by this paper
• Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture.

  1989cited by this paper
• Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes.

  1988cited by this paper
• Macrophages associated with murine tumours express plasminogen activator activity

  1988cited by this paper
• Expression of plasminogen activator as a marker of stimulation in tumor-associated macrophages.

  1988cited by this paper
• Human breast and colon carcinomas express cysteine proteinase activities with pro‐aggregating and pro‐coagulant properties

  1988cited by this paper
• The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer.

  1988cited by this paper
• A new procoagulant in acute leukemia.

  1988cited by this paper
• Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics

  1987cited by this paper
• Thrombin stimulates arachidonate metabolism in murine tumor cells

  1987cited by this paper
• Effects of dimethyl sulfoxide (DMSO) on microfilament organization, cellular adhesion, and growth of cultured mouse B16 melanoma cells.

  1987cited by this paper
• Induction of monocyte-macrophage procoagulant activity by transformed cell lines.

  1986cited by this paper
• Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.

  1986cited by this paper
• Enhancement by interleukin-1 (IL-1) of plasminogen activator inhibitor (PA-I) activity in cultured human endothelial cells.

  1986cited by this paper
• Procoagulant and fibrinolytic activity of human ovarian carcinoma cells in culture.

  1986cited by this paper
• Vitamin K-dependent procoagulant in cancer cells: a potential target for the antimetastatic effect of warfarin?

  1986cited by this paper
• Monocyte procoagulant inducing factor: a lymphokine involved in the T cell-instructed monocyte procoagulant response to antigen.

  1986cited by this paper
• Cancer procoagulant in human tumor cells: evidence from melanoma patients.

  1986cited by this paper
• gamma-Glutamyl carboxylase activity in experimental tumor tissues: a biochemical basis for vitamin K dependence of cancer procoagulant.

  1986cited by this paper
• Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue.

  1985cited by this paper
• Effects of chemotherapeutic drugs on platelet and metastatic tumor cell-endothelial cell interactions as a model for assessing vascular endothelial integrity.

  1985cited by this paper
• Cysteine proteinase procoagulant from amnion-chorion.

  1985cited by this paper
• Procoagulant activity of macrophages associated with different murine neoplasms

  1984cited by this paper
• Cancer cell procoagulants and their pharmacological modulation.

  1984cited by this paper
• Plasminogen activator activity of metastatic variants from a murine fibrosarcoma; effect of thrombin in vitro

  1983cited by this paper
• Warfarin inhibits both procoagulant activity and metastatic capacity of Lewis lung carcinoma cells. Role of vitamin K deficiency.

  1983cited by this paper
• Generation of procoagulant activity by mononuclear phagocytes: a possible mechanism contributing to blood clotting activation within malignant tissues.

  1983cited by this paper
• Distribution of cardiac output during development of two metastasizing murine tumors.

  1983cited by this paper
• Cancer cell procoagulant: a novel vitamin K-dependent activity.

  1981cited by this paper
• Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line.

  1980cited by this paper
• MALIGNANCY AND HAEMOSTASIS

  1980cited by this paper
• Altered viscosity and yield stress in patients with abdominal malignancy: Relationship to deep vein thrombosis

  1976cited by this paper
• Phlegmasia alba dolens.

  year unknowncited by this paper

• Predictors of cancer in patients with acute pulmonary embolism.

  2023cites this paper
• Unintentional Dual Benefit: Improvement in Secondary Polycythemia in a Patient Receiving Chemotherapy for Metastatic Clear Cell Renal Cell Carcinoma

  2022cites this paper
• Elevation of the d-dimer cut-off level might be applicable to rule out pulmonary embolism for active cancer patients in the emergency department

  2021cites this paper
• Relationship between platelet-based models and the prognosis of patients with malignant hepatic tumors

  2020cites this paper
• Inflammatory cell-associated tumors. Not only macrophages (TAMs), fibroblasts (TAFs) and neutrophils (TANs) can infiltrate the tumor microenvironment. The unique role of tumor associated platelets (TAPs)

  2020cites this paper
• Use of Warfarin or Direct Oral Anticoagulants and Risk of Prostate Cancer in PCBaSe: A Nationwide Case-Control Study

  2020cites this paper
• An overview of thrombotic complications of old and new anticancer drugs.

  2020cites this paper
• Sudden, Unexpected Death Due to Pseudo-Meigs Syndrome: A Case Report and Review of the Literature.

  2019cites this paper
• Clinical features of pulmonary embolism in patients with lung cancer: A meta-analysis

  2019cites this paper
• Cancer‐associated thrombosis: The search for the holy grail continues

  2018cites this paper
• Platelet Distribution Width in Hepatocellular Carcinoma

  2018cites this paper
• HYPERCOAGULABILITY IN PATIENTS WITH LUNG CANCER UNDERGOING CHEMOTHERAPY

  2018cites this paper
• A Case of Varicose Veins of a Leg with Thrombophlebitis Complicated by a Malignant Disease

  2018cites this paper
• Stroke in Critically Ill Cancer Patients

  2018cites this paper
• Pulmonary embolism concurrent with lung cancer and central emboli predict mortality in patients with lung cancer and pulmonary embolism.

  2018cites this paper
• Platelets in cancer metastasis: To help the “villain” to do evil

  2016cites this paper
• Impact of Transfusion on Cancer Growth and Outcome

  2016cites this paper
• Venous Thromboembolism in Patients Diagnosed With Lung Cancer

  2016cites this paper
• Thrombin activatable fibrinolysis inhibitor (TAFI), tissue factor pathway inhibitor (TFPI), and prothrombin fragment 1+2 levels in patients with advanced colorectal cancer

  2016cites this paper
• Thrombin activatable fibrinolysis inhibitor, tissue factor pathway inhibitor, and prothrombin fragment 1+2 levels in patients with advanced colorectal cancer.

  2016cites this paper
• Trombosis en mieloma múltiple hemostasia y citocinas implicadas

  2016cites this paper
• Патогенетические особенности профилактики тромбогеморрагических осложнений у онкогинекологических больных

  2016cites this paper
• Prostate cancer: beware of disseminated intravascular coagulation

  2015cites this paper
• LUNG CANCER AND PULMONARY THROMBOEMBOLISM

  2015cites this paper
• Hydrophilic interaction chromatography coupled to tandem mass spectrometry in the presence of hydrophilic ion-pairing reagents for the separation of nucleosides and nucleotide mono-, di- and triphosphates.

  2015cites this paper
• Protecting travelling pets and their owners from disease – the role of the veterinarian

  2014cites this paper
• Targeted metabolic analysis of nucleotides and identification of biomarkers associated with cancer in cultured cell models

  2013cites this paper
• Cancer-associated thrombosis: clinical presentation and survival

  2013cites this paper
• Protein S: A multifunctional anticoagulant vitamin K-dependent protein at the crossroads of coagulation, inflammation, angiogenesis, and cancer.

  2013cites this paper
• Current Practice Managements Regarding Thromboembolic Prophylaxis Within the Pediatric Sarcoma Patient Population

  2013cites this paper
• DETERMINAÇÃO DA ATIVIDADE DAS ENZIMAS QUE DEGRADAM NUCLEOTÍDEOS DA ADENINA EM PACIENTES COM CÂNCER DE PRÓSTATA

  2013cites this paper
• The Role of Platelets in Angiogenesis

  2013cites this paper
• The platelet-cancer loop.

  2013cites this paper
• Right atrial thrombus in cholangiocellular carcinoma: Case report and a review of the literature

  2013cites this paper
• Squamous cell carcinoma lung: Presented with bilateral lower limb deep venous thrombosis with gangrene formation

  2013cites this paper
• Development of breast cancer diagnosis tool using hybrid magnetoacoustic method and artificial neural network

  2012cites this paper
• Anticoagulant and fibrinolytic drugs - possible agents in treatment of lung cancer?

  2012cites this paper
• Platelets, Coagulation and Cancer: Multifaceted Interactions

  2012cites this paper
• Stres oksydacyjny w raku piersi

  2012cites this paper
• The Role of Platelets in Tumour Growth Úloha krevních destiček v rozvoji nádoru

  2012cites this paper
• Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: results from a prospective cohort study with Asian population.

  2012cites this paper
• Role of the purinergic system in patients with cervical intraepithelial neoplasia and uterine cancer.

  2012cites this paper
• Lung cancer alters the hydrolysis of nucleotides and nucleosides in platelets.

  2012cites this paper
• The role of platelets in tumour growth.

  2012cites this paper
• Diagnosis prevention and treatment for PICC‐related upper extremity deep vein thrombosis in breast cancer patients

  2012cites this paper
• Tumoral thrombosis of inferior vena cava and iliac veins resulting in unilateral lower limb edema in a young adult: A rare presentation of skeletal Ewing's sarcoma

  2011cites this paper
• Is Genetic Screening Necessary for Determining the Possibility of Venous Thromboembolism in Cancer Patients?

  2011cites this paper
• A novel tissue imaging method using short pulse magneto acoustic wave

  2011cites this paper
• Expression of coagulation factors and their receptors in tumor tissue and coagulation factor upregulation in peripheral blood of patients with cerebral carcinoma metastases

  2011cites this paper
• The association between vitamin K antagonist therapy and site-specific cancer incidence estimated by using heart valve replacement as an instrumental variable.

  2011cites this paper
• Increased risk of venous thromboembolism in patients with primary mediastinal large B-cell lymphoma.

  2010cites this paper
• Is mitral regurgitant jet offensive rather than protective for left atrial thrombus?

  2010cites this paper
• Purified thromboplastin causes haemostatic abnormalities but not overt DIC in an experimental rabbit model.

  2010cites this paper
• Implementation of the ISTH classification of non-overt DIC in a thromboplastin induced rabbit model.

  2009cites this paper
• Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy.

  2009cites this paper
• A Nickel's Worth of Cancer

  2008cites this paper
• Role of alternatively spliced tissue factor in pancreatic cancer growth and angiogenesis.

  2008cites this paper
• Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer

  2008cites this paper
• Role of Alternatively Spliced Tissue Factor in Pancreatic Cancer Growth and Angiogenesis

  2008cites this paper
• Increased procoagulant activity of red blood cells in the presence of cisplatin.

  2008cites this paper
• Clinical Course of Pulmonary Embolism in Lung Cancer Patients

  2008cites this paper
• The role of thrombomodulin in malignancy.

  2007cites this paper
• Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients.

  2007cites this paper
• Disseminated intravascular coagulation

  2007cites this paper
• Pharmacokinetics in cancer chemotherapy.

  2007cites this paper
• Thromboembolic events in children and young adults with pediatric sarcoma.

  2007cites this paper
• The Role of Thrombomodulin in Malignancy

  2007cites this paper
• Prevalence of Factor V 1691 G–A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients

  2007cites this paper
• A case of trousseaus syndrome associated with adenocarcinoma of the lung

  2007cites this paper
• Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review

  2007cites this paper
• Thrombosis and cancer: A personal view

  2007cites this paper
• Procoagulant factors in patients with cancer

  2007cites this paper
• Thrombosis in multiple myeloma

  2007cites this paper
• The Effect of Anthracycline-Based (Epirubicin) Adjuvant Chemotherapy on Plasma TAFI and PAI-1 Levels in Operable Breast Cancer

  2006cites this paper
• Gerinnungsstörungen bei neurochirurgischen Tumorpatienten

  2006cites this paper
• Factores procoagulantes en pacientes con cáncer* Procoagulant factors in patients with cancer

  2006cites this paper
• Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation

  2006cites this paper
• Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence.

  2005cites this paper
• Pathophysiology, diagnosis and treatment of disseminated intravascular coagulation: an update.

  2005cites this paper
• Transcriptomic and proteomic approaches to the discovery of new markers of pathology

  2005cites this paper
• Hemostasia y cáncer: Participación del mecanismo de la coagulación en el cáncer

  2005cites this paper
• Enzymes that hydrolyze adenine nucleotides in platelets from breast cancer patients.

  2005cites this paper
• Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer.

  2005cites this paper
• Primary intimal sarcoma of the thoracic aorta.

  2005cites this paper
• Haemostatic alterations in colorectal cancer: Perspectives for future treatment

  2004cites this paper
• The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma

  2004cites this paper
• Current understanding of disseminated intravascular coagulation

  2004cites this paper
• [Recurrent ischemic strokes secondary to acquired hypercoagulability in a patient with prostatic adenocarcinoma].

  2004cites this paper
• Risk Assessment and Treatment of Bleeding in Cancer Patients

  2003cites this paper
• Therapeutic Options in Patients with DIC and Cancer

  2003cites this paper
• Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease

  2003cites this paper
• Anti-thrombotic therapy in cancer patients

  2003cites this paper
• Primary aortic sarcoma with widespread vascular embolic metastases.

  2003cites this paper
• All-trans retinoic acid modulates microvascular endothelial cell hemostatic properties.

  2003cites this paper
• The role of tissue factor in colorectal cancer.

  2003cites this paper
• Coagulopathic complications in breast cancer

  2003cites this paper
• Coagulation Factors and Tumor Cell Biology: The Role of Tissue Factor

  2003cites this paper
• Increased exposure of anionic phospholipids on the surface of tumor blood vessels.

  2002cites this paper
• Tissue factor and angiogenesis in cancer

  2002cites this paper
• Medical management of patients with brain tumors

  2002cites this paper